Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing anti-HIV drug combinations to prevent mother-to-child transmission of HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED